PATENT CLAIM ANALYSIS

Application Number: 16078431
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "304000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases and disorders.

Claim (Index 7):
The method according to  claim 1 , wherein the FXR agonist compound is Compound A or an amino acid conjugate thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14012401', '11819517', '15263033', '16030141', '14743295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787473553183563
- 35 USC 102 Novelty (BERT): 0.5119691683543962
- Combined Prediction Score: 0.7520695366219602
- Mean Citation Score: 248.90263
- Max Citation Score: 260.66025
- Similarity Product: 167.61231077089906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test